Comparing two IVF medications for egg and embryo quality
Part of Hormones & metabolism, Women’s health & pregnancy clinical trials.
This study compares two fertility medications (rFSH and hMG) to see how they affect the cells around your eggs and the quality of embryos. It may help you and your doctor choose the best stimulation drug for your IVF cycle.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 38 years old.
- You are planning to have your embryos genetically tested (PGT-A).
- Your body mass index (BMI) is between 18 and 30.
- You have a regular menstrual cycle (25 to 32 days).
- You and your partner agree to do two rounds of ovarian stimulation before moving to embryo transfer.
- You have no major womb issues, no endometriosis stage 3 or higher, and have had fewer than 2 miscarriages.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares two hormone protocols for ovarian stimulation in women having their first cycle—either to freeze eggs for fertility preservation or for IVF with genetic testing. The goal is to see which method leads to more usable eggs while being easier on the patient.
This study tests a different type of fertility medication to help women who had fewer than 9 eggs retrieved in a previous IVF cycle. It's designed for women between 18 and 40 with a specific hormone profile, and aims to improve egg collection results.
This trial tests a new way to stimulate ovaries after ovulation using a single injection of Elonva, compared to a standard method starting on day 2 of the menstrual cycle. It aims to see which approach leads to more mature eggs for IVF or ICSI.
This trial tests how well a hormone treatment (hMG) works for people doing IVF with genetic screening of embryos. It may help if you have normal ovarian reserve and are not using donor sperm.
This trial compares two starting doses of follicle-stimulating hormone (FSH) during in vitro fertilization (IVF) to see which works better. FSH helps your ovaries produce eggs, and the study aims to find the best dose for women with good fertility prospects.
This trial tests whether a lower or higher dose of follicle-stimulating hormone (FSH) works better for women with normal egg supply. If you are starting your first or second IVF cycle, you may be able to join.
Hear when a new OVARIAN STIMULATION trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.